
Rockwell Medical (($RMTI)) has held its Q3 earnings call. Read on for the main highlights of the call. Rockwell Medical’s earnings call struck a strongly optimistic tone around growth in
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RMTI | Rockwell Med | 6.28 | -2.57 | -29.05% |
| Name | Price | % Change | |
|---|---|---|---|
| $6.28 | -29.05% |

Rockwell Medical (($RMTI)) has held its Q3 earnings call. Read on for the main highlights of the call. Rockwell Medical’s earnings call struck a strongly optimistic tone around growth in

Rockwell Medical (RMTI) has disclosed a new risk, in the Regulation category. He notes that regulatory approvals for the Vantive Transaction, including Italian golden power, foreign investment and merger control

Rockwell Medical (RMTI) is scheduled to report 3rd quarter earnings on 11/12/2026, before the market opens. Regarding Q3 estimates, Wall Street analysts expect Rockwell Medical to post earnings of -$0.18

Rockwell Med ( ($RMTI) ) has issued an announcement. On November 2, 2026, Rockwell Medical entered an agreement to acquire Vantive’s in-center hemodialysis business across 35 jurisdictions, including the United

Rockwell Medical (RMTI) announced that it has entered into an Equity and Asset Purchase Agreement with Vantive Limited. Subject to the terms of the Agreement, Rockwell Medical will acquire Vantive’s

Rockwell Medical (RMTI) is withdrawing its previously issued 2026 guidance for Net Sales, Gross Margin, Adjusted EBITDA and Operating Cash Flow due to projected expenses related to expected transaction-related and

Analyst Anthony Vendetti from Maxim Group maintained a Buy rating on Rockwell Med and decreased the price target to $20.00 from $40.00. Anthony Vendetti has given his Buy rating due

Reports Q2 revenue $17.8M vs. $16.1M last year. “The momentum in our business continues to build. Our second quarter results reflect the outcome of the actions we have taken to

Sees 2026 adjusted EBITDA $1.0M-$2.0M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read

Rockwell Medical (($RMTI)) has held its Q2 earnings call. Read on for the main highlights of the call. Rockwell Medical’s latest earnings call struck a cautiously optimistic tone, with management
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Apr 1, 2027TBA | $26.64M | $-0.43 | $19.00M | -0.01 | -4.12 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.